CNCR Holdings

The Cancer Immunotherapy ETF

ETF Information as of 08/17/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
MIRATI THERAPEUTICS INC MRTX 60468T105 48,638 $2,915,848.10 5.27%
BRISTOL MYERS SQUIBB CO BMY 110122108 45,050 $2,743,094.50 4.96%
IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 183,465 $2,733,628.50 4.94%
MERCK & CO INC MRK 58933Y105 39,022 $2,694,859.32 4.87%
NOVARTIS A G NVS 66987V109 31,784 $2,639,343.36 4.77%
NEKTAR THERAPEUTICS NKTR 640268108 42,602 $2,557,398.06 4.62%
ASTRAZENECA PLC AZN 046353108 66,757 $2,544,776.84 4.60%
GILEAD SCIENCES INC GILD 375558103 33,781 $2,463,310.52 4.45%
MORPHOSYS AG MOR 617760202 83,720 $2,368,438.80 4.28%
XENCOR INC XNCR 98401F105 58,714 $2,346,211.44 4.24%
FATE THERAPEUTICS INC FATE 31189P102 199,024 $2,229,068.80 4.03%
CELLECTIS S A CLLS 15117K103 77,173 $2,183,995.90 3.95%
BEIGENE LTD BGNE 07725L102 13,739 $2,161,419.48 3.91%
CYTOMX THERAPEUTICS INC CTMX 23284F105 95,742 $2,153,237.58 3.89%
MACROGENICS INC MGNX 556099109 106,807 $2,137,208.07 3.86%
ZYMEWORKS INC ZYME 98985W102 145,467 $2,062,722.06 3.73%
ARCUS BIOSCIENCES INC RCUS 03969F109 149,635 $1,985,656.45 3.59%
BLUEBIRD BIO INC BLUE 09609G100 12,200 $1,927,600.00 3.48%
DYNAVAX TECHNOLOGIES CORP DVAX 268158201 151,906 $1,914,015.60 3.46%
ATARA BIOTHERAPEUTICS INC ATRA 046513107 52,644 $1,889,919.60 3.42%
FIVE PRIME THERAPEUTICS INC FPRX 33830X104 136,232 $1,795,537.76 3.25%
ADURO BIOTECH INC ADRO 00739L101 312,092 $1,794,529.00 3.24%
SORRENTO THERAPEUTICS INC SRNE 83587F202 327,610 $1,752,713.50 3.17%
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAP 00653A107 197,131 $1,671,670.88 3.02%
ZIOPHARM ONCOLOGY INC ZIOP 98973P101 562,787 $1,609,570.82 2.91%
Cash & Other Cash&Other Cash&Other 38,535.06 $38,535.06 0.07%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities